These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 25617880)

  • 21. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G; Anderson G; Maes M
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
    Maes M; Galecki P; Chang YS; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):676-92. PubMed ID: 20471444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability.
    Maes M; Mihaylova I; Leunis JC
    J Affect Disord; 2007 Apr; 99(1-3):237-40. PubMed ID: 17007934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a nitro-oxidative stress-driven, mechanistic model of mood disorders: A nomothetic network approach.
    Simeonova D; Stoyanov D; Leunis JC; Murdjeva M; Maes M
    Nitric Oxide; 2021 Jan; 106():45-54. PubMed ID: 33186727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology.
    Maes M; Mihaylova I; Kubera M; Leunis JC; Geffard M
    J Affect Disord; 2011 Dec; 135(1-3):414-8. PubMed ID: 21930301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural regulatory IgM-mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy.
    Roomruangwong C; Barbosa DS; de Farias CC; Matsumoto AK; Baltus THL; Morelli NR; Kanchanatawan B; Duleu S; Geffard M; Maes M
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):116-130. PubMed ID: 29194848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression.
    Maes M; Kubera M; Mihaylova I; Geffard M; Galecki P; Leunis JC; Berk M
    J Affect Disord; 2013 Jul; 149(1-3):23-9. PubMed ID: 22898471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic fatigue syndrome: la bête noire of the Belgian health care system.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(3):300-11. PubMed ID: 19855351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Maes M; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Med Sci Monit; 2011 Apr; 17(4):SC11-5. PubMed ID: 21455120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
    Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
    Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
    Maes M; Twisk FN; Johnson C
    Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
    Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
    Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
    Morris G; Berk M; Galecki P; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):741-56. PubMed ID: 24068616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
    Twisk FN; Maes M
    Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut.
    Maes M; Kubera M; Leunis JC; Berk M
    J Affect Disord; 2012 Dec; 141(1):55-62. PubMed ID: 22410503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.
    Morris G; Maes M
    Metab Brain Dis; 2013 Dec; 28(4):523-40. PubMed ID: 22718491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.